scPharmaceuticals Inc.
SCPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $76 | $47 | $71 | $74 |
| Short-Term Investments | $0 | $29 | $47 | $1 |
| Receivables | $12 | $4 | $0 | $0 |
| Inventory | $14 | $9 | $1 | $0 |
| Other Curr. Assets | $5 | $4 | $4 | $3 |
| Total Curr. Assets | $106 | $93 | $123 | $78 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $108 | $94 | $124 | $79 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $1 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $11 | $9 | $5 | $4 |
| Total Curr. Liab. | $15 | $13 | $7 | $15 |
| LT Debt | $52 | $40 | $37 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $27 | $4 | $8 | $0 |
| Total NC Liab. | $79 | $44 | $44 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $0 |
| Total Liabilities | $94 | $57 | $52 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$366 | -$281 | -$227 | -$190 |
| AOCI | $0 | -$0 | $0 | -$0 |
| Other Equity | $380 | $319 | $299 | $246 |
| Total Equity | $13 | $37 | $72 | $56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $108 | $94 | $124 | $79 |
| Net Debt | -$23 | -$6 | -$33 | -$57 |